{"ok":true,"trend":{"id":243958,"platform":"news","region":"global","key":"kodiak sciences says eye drug on par with regeneron's medicine","title":"Kodiak Sciences Says Eye Drug on Par with Regeneron's Medicine","url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPTUgtaHp0YkRwdF92TEUza2pxZUVTNXktSkw3dVpvRENLRU9DdlhMUVVJdXhtOGwtNV9JaWtha1loR1FEN09hTGJKY2x1Zm1FNF9WQXJFcVFIQWtkMUpUUVMzcmRfNGlGR2p5M184NXdlQ0ZuTnd4aVAtd0JkYTlua1ROOXFHcEtyamRTOG9YSVdzdExEWXR6T1daR0VlYmF1UlZlMy1RbUcwV01vTjY5VHhtMUtXaXZ4Vml2MU1rcw?oc=5","first_seen":"2026-09-28T14:41:11.897021Z","last_seen":"2026-09-28T18:48:55.179259Z","last_rank":34,"peak_rank":19,"last_volume":null,"peak_volume":0,"seen_count":4,"score":23.93,"category_hint":"medicine","section":"health","category":"medicine","summary":"Kodiak Sciences announced that its experimental eye drug performs on par with Regeneron's established treatment, according to a Benzinga report. The claim, if supported by trial data, would position the biotech as a credible challenger in the competitive market for retinal disease therapies, where Regeneron's medicine has long been a dominant option.","why":"Investors and eye-care specialists are reacting to Kodiak Sciences' claim that its drug is as effective as Regeneron's leading therapy.","tone":"neutral","entities":["Kodiak Sciences","Regeneron"],"summarized_at":"2026-09-28T20:43:11.441087Z","meta":{"via":"scan","lang":"en","term":"medicine","source":"Benzinga","generic":0.05,"published":"Mon, 28 Sep 2026 14:05:22 GMT"},"nw":0.59,"promo":0.04,"kind":"news_event","importance":1.45,"hidden":false,"hide_reason":null,"judged_at":"2026-09-28T14:41:13.692555Z","title_en":"Kodiak Sciences Says Its Eye Drug Matches Regeneron's Medicine","section_name":"Health","category_name":"Medicine","timeline":[{"captured_at":"2026-09-28T14:41:11.897021Z","rank":19,"volume":null},{"captured_at":"2026-09-28T16:04:55.903930Z","rank":27,"volume":null},{"captured_at":"2026-09-28T17:26:55.335328Z","rank":27,"volume":null},{"captured_at":"2026-09-28T18:48:55.179259Z","rank":34,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPTUgtaHp0YkRwdF92TEUza2pxZUVTNXktSkw3dVpvRENLRU9DdlhMUVVJdXhtOGwtNV9JaWtha1loR1FEN09hTGJKY2x1Zm1FNF9WQXJFcVFIQWtkMUpUUVMzcmRfNGlGR2p5M184NXdlQ0ZuTnd4aVAtd0JkYTlua1ROOXFHcEtyamRTOG9YSVdzdExEWXR6T1daR0VlYmF1UlZlMy1RbUcwV01vTjY5VHhtMUtXaXZ4Vml2MU1rcw?oc=5","author":"Benzinga","title":"Kodiak Sciences Says Eye Drug on Par with Regeneron's Medicine","snippet":null,"posted_at":"2026-09-28T14:05:22Z","likes":null}],"elsewhere":[],"window":"7d"}}